Marcelo Perraillon
Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medicare | 17 | 2025 | 718 | 4.100 |
Why?
| Nursing Homes | 5 | 2019 | 151 | 1.410 |
Why?
| Dementia | 4 | 2022 | 227 | 1.380 |
Why?
| Preventive Health Services | 2 | 2023 | 144 | 1.270 |
Why?
| Fee-for-Service Plans | 5 | 2023 | 88 | 1.270 |
Why?
| Medicare Part C | 2 | 2025 | 30 | 1.120 |
Why?
| Patient Acceptance of Health Care | 2 | 2025 | 764 | 1.030 |
Why?
| Neoplasms | 5 | 2023 | 2465 | 1.010 |
Why?
| SEER Program | 2 | 2024 | 206 | 1.010 |
Why?
| Medicaid | 5 | 2023 | 437 | 1.010 |
Why?
| United States | 34 | 2025 | 13876 | 0.980 |
Why?
| Depression, Postpartum | 2 | 2025 | 129 | 0.980 |
Why?
| Fathers | 1 | 2025 | 48 | 0.930 |
Why?
| Carcinoma, Non-Small-Cell Lung | 2 | 2025 | 1044 | 0.890 |
Why?
| Drug Costs | 2 | 2025 | 103 | 0.870 |
Why?
| Registries | 6 | 2023 | 1878 | 0.850 |
Why?
| Comparative Effectiveness Research | 1 | 2023 | 151 | 0.770 |
Why?
| Information Dissemination | 2 | 2022 | 204 | 0.770 |
Why?
| Aged, 80 and over | 18 | 2025 | 7040 | 0.770 |
Why?
| Antineoplastic Agents | 2 | 2025 | 2058 | 0.750 |
Why?
| Lung Neoplasms | 3 | 2025 | 2323 | 0.740 |
Why?
| Breast Neoplasms | 2 | 2024 | 2139 | 0.740 |
Why?
| Medical Record Linkage | 1 | 2021 | 59 | 0.720 |
Why?
| Aged | 26 | 2025 | 21971 | 0.720 |
Why?
| Mental Status and Dementia Tests | 1 | 2021 | 23 | 0.720 |
Why?
| Early Detection of Cancer | 2 | 2024 | 368 | 0.700 |
Why?
| Insurance Coverage | 4 | 2023 | 222 | 0.650 |
Why?
| Preventive Medicine | 1 | 2019 | 41 | 0.650 |
Why?
| Colorado | 8 | 2025 | 4392 | 0.620 |
Why?
| Research | 1 | 2022 | 409 | 0.610 |
Why?
| Mothers | 1 | 2025 | 728 | 0.610 |
Why?
| Nootropic Agents | 1 | 2018 | 28 | 0.600 |
Why?
| Medicare Part D | 1 | 2018 | 24 | 0.600 |
Why?
| Health Facility Administrators | 1 | 2017 | 4 | 0.570 |
Why?
| Quality Indicators, Health Care | 2 | 2017 | 296 | 0.570 |
Why?
| Pneumonia | 4 | 2013 | 599 | 0.520 |
Why?
| Homes for the Aged | 1 | 2016 | 25 | 0.510 |
Why?
| Depression | 1 | 2025 | 1289 | 0.510 |
Why?
| Skilled Nursing Facilities | 4 | 2022 | 128 | 0.500 |
Why?
| Humans | 47 | 2025 | 128524 | 0.490 |
Why?
| Healthcare Disparities | 2 | 2018 | 576 | 0.470 |
Why?
| Female | 31 | 2025 | 68127 | 0.450 |
Why?
| Clinical Coding | 2 | 2013 | 20 | 0.430 |
Why?
| Internet | 1 | 2016 | 618 | 0.380 |
Why?
| Male | 25 | 2025 | 62883 | 0.370 |
Why?
| Hospitalization | 6 | 2025 | 2071 | 0.350 |
Why?
| Antidepressive Agents | 2 | 2014 | 221 | 0.330 |
Why?
| Retrospective Studies | 12 | 2025 | 14460 | 0.320 |
Why?
| Alaska Natives | 2 | 2022 | 138 | 0.320 |
Why?
| Health Care Costs | 3 | 2022 | 395 | 0.290 |
Why?
| Stroke | 3 | 2019 | 1064 | 0.290 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 1271 | 0.280 |
Why?
| Socioeconomic Factors | 3 | 2018 | 1197 | 0.250 |
Why?
| Risk Factors | 7 | 2025 | 9727 | 0.250 |
Why?
| Cohort Studies | 3 | 2025 | 5369 | 0.240 |
Why?
| Community-Acquired Infections | 3 | 2013 | 152 | 0.240 |
Why?
| Heart Failure | 4 | 2022 | 2150 | 0.230 |
Why?
| Long-Term Care | 1 | 2015 | 89 | 0.230 |
Why?
| Patient Discharge | 4 | 2023 | 849 | 0.230 |
Why?
| Patient Readmission | 3 | 2023 | 664 | 0.230 |
Why?
| Insurance Claim Review | 2 | 2021 | 72 | 0.220 |
Why?
| Interviews as Topic | 2 | 2017 | 705 | 0.220 |
Why?
| Patient Protection and Affordable Care Act | 2 | 2022 | 101 | 0.210 |
Why?
| Early Medical Intervention | 1 | 2024 | 58 | 0.210 |
Why?
| Hospice Care | 2 | 2024 | 199 | 0.210 |
Why?
| Mammography | 1 | 2024 | 143 | 0.210 |
Why?
| Self-Injurious Behavior | 1 | 2014 | 120 | 0.210 |
Why?
| Health Surveys | 1 | 2015 | 492 | 0.210 |
Why?
| Causality | 1 | 2023 | 114 | 0.200 |
Why?
| Diabetes Complications | 2 | 2021 | 224 | 0.200 |
Why?
| Hormones | 1 | 2023 | 140 | 0.200 |
Why?
| Anti-Infective Agents | 2 | 2022 | 225 | 0.200 |
Why?
| Databases, Factual | 3 | 2021 | 1268 | 0.190 |
Why?
| State Government | 1 | 2022 | 43 | 0.190 |
Why?
| Nervous System Malformations | 1 | 2022 | 35 | 0.190 |
Why?
| Central Nervous System Infections | 1 | 2022 | 35 | 0.190 |
Why?
| Adult | 11 | 2025 | 35315 | 0.190 |
Why?
| Nutritional Status | 1 | 2024 | 326 | 0.180 |
Why?
| Suicide, Attempted | 1 | 2014 | 352 | 0.180 |
Why?
| Young Adult | 4 | 2025 | 12320 | 0.180 |
Why?
| Case Management | 1 | 2021 | 63 | 0.180 |
Why?
| Terminal Care | 1 | 2024 | 238 | 0.180 |
Why?
| Meningitis | 1 | 2022 | 80 | 0.180 |
Why?
| Health Expenditures | 1 | 2022 | 184 | 0.170 |
Why?
| Encephalitis | 1 | 2022 | 132 | 0.170 |
Why?
| Hospital Mortality | 2 | 2013 | 844 | 0.170 |
Why?
| Cost Savings | 1 | 2019 | 79 | 0.160 |
Why?
| Case-Control Studies | 2 | 2025 | 3326 | 0.160 |
Why?
| Antipsychotic Agents | 2 | 2008 | 194 | 0.160 |
Why?
| Length of Stay | 2 | 2013 | 1121 | 0.160 |
Why?
| Population Surveillance | 1 | 2022 | 427 | 0.150 |
Why?
| Pregnant Women | 1 | 2019 | 118 | 0.150 |
Why?
| Hip Fractures | 1 | 2009 | 82 | 0.150 |
Why?
| Health Facility Closure | 1 | 2018 | 8 | 0.150 |
Why?
| Neoplasm Metastasis | 1 | 2020 | 608 | 0.150 |
Why?
| Economics, Hospital | 1 | 2018 | 21 | 0.140 |
Why?
| Legislation, Food | 1 | 2017 | 2 | 0.140 |
Why?
| Longitudinal Studies | 1 | 2025 | 2697 | 0.140 |
Why?
| Trans Fatty Acids | 1 | 2017 | 6 | 0.140 |
Why?
| Independent Living | 1 | 2018 | 97 | 0.140 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 950 | 0.140 |
Why?
| Health Services Accessibility | 3 | 2022 | 892 | 0.140 |
Why?
| Colorectal Neoplasms | 1 | 2025 | 753 | 0.140 |
Why?
| Pregnancy Outcome | 1 | 2019 | 383 | 0.140 |
Why?
| Middle Aged | 9 | 2025 | 30893 | 0.140 |
Why?
| Pregnancy | 3 | 2025 | 6297 | 0.140 |
Why?
| Indians, North American | 1 | 2022 | 600 | 0.130 |
Why?
| Poverty | 1 | 2019 | 494 | 0.130 |
Why?
| Residence Characteristics | 1 | 2018 | 324 | 0.120 |
Why?
| Smoking Cessation | 1 | 2019 | 408 | 0.120 |
Why?
| Awareness | 1 | 2016 | 99 | 0.120 |
Why?
| Motivation | 1 | 2019 | 537 | 0.120 |
Why?
| Depressive Disorder, Major | 1 | 2008 | 347 | 0.120 |
Why?
| Insurance, Health, Reimbursement | 1 | 2015 | 96 | 0.110 |
Why?
| Frail Elderly | 1 | 2015 | 119 | 0.110 |
Why?
| Mass Screening | 1 | 2022 | 1152 | 0.110 |
Why?
| Health Care Surveys | 1 | 2016 | 557 | 0.110 |
Why?
| Qualitative Research | 2 | 2022 | 1205 | 0.110 |
Why?
| Needs Assessment | 1 | 2016 | 360 | 0.110 |
Why?
| Patient Compliance | 1 | 2007 | 562 | 0.110 |
Why?
| Medication Adherence | 1 | 2008 | 573 | 0.110 |
Why?
| Physicians | 1 | 2022 | 860 | 0.110 |
Why?
| Patient-Centered Care | 1 | 2018 | 493 | 0.110 |
Why?
| Data Collection | 1 | 2016 | 649 | 0.100 |
Why?
| Diabetes Mellitus | 1 | 2021 | 1001 | 0.100 |
Why?
| Logistic Models | 3 | 2013 | 1975 | 0.100 |
Why?
| Adolescent | 3 | 2025 | 20213 | 0.090 |
Why?
| Health Personnel | 1 | 2017 | 646 | 0.090 |
Why?
| Incidence | 3 | 2014 | 2619 | 0.090 |
Why?
| Quality of Health Care | 1 | 2015 | 607 | 0.090 |
Why?
| Myocardial Infarction | 1 | 2017 | 1014 | 0.080 |
Why?
| Outpatients | 2 | 2011 | 366 | 0.060 |
Why?
| Drug Prescriptions | 2 | 2008 | 250 | 0.060 |
Why?
| Aging | 1 | 2016 | 1770 | 0.060 |
Why?
| Comorbidity | 2 | 2011 | 1540 | 0.060 |
Why?
| Cross-Sectional Studies | 2 | 2023 | 5040 | 0.050 |
Why?
| Death | 1 | 2023 | 122 | 0.050 |
Why?
| Subacute Care | 1 | 2023 | 73 | 0.050 |
Why?
| United States Indian Health Service | 1 | 2022 | 42 | 0.050 |
Why?
| Morbidity | 1 | 2022 | 302 | 0.040 |
Why?
| Pharmaceutical Services | 1 | 2021 | 83 | 0.040 |
Why?
| Schools | 1 | 2024 | 439 | 0.040 |
Why?
| Age Distribution | 1 | 2011 | 376 | 0.040 |
Why?
| Sex Distribution | 1 | 2011 | 359 | 0.040 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2009 | 26 | 0.040 |
Why?
| Observation | 1 | 2009 | 51 | 0.040 |
Why?
| Pneumococcal Vaccines | 1 | 2011 | 139 | 0.040 |
Why?
| Child | 3 | 2024 | 20721 | 0.040 |
Why?
| Symptom Assessment | 1 | 2020 | 125 | 0.040 |
Why?
| Diphosphonates | 1 | 2009 | 58 | 0.040 |
Why?
| Respiratory Insufficiency | 1 | 2013 | 311 | 0.040 |
Why?
| Streptococcus pneumoniae | 1 | 2011 | 159 | 0.040 |
Why?
| Infant | 2 | 2024 | 8913 | 0.040 |
Why?
| Bone Density Conservation Agents | 1 | 2009 | 73 | 0.040 |
Why?
| Drug Utilization | 1 | 2009 | 167 | 0.040 |
Why?
| Documentation | 1 | 2020 | 182 | 0.040 |
Why?
| Mortality | 1 | 2011 | 307 | 0.040 |
Why?
| Estrogen Replacement Therapy | 1 | 2009 | 142 | 0.040 |
Why?
| Treatment Outcome | 2 | 2021 | 10163 | 0.040 |
Why?
| Odds Ratio | 1 | 2011 | 1022 | 0.040 |
Why?
| Disease Management | 1 | 2022 | 588 | 0.040 |
Why?
| Proportional Hazards Models | 1 | 2010 | 1208 | 0.040 |
Why?
| Models, Biological | 1 | 2014 | 1693 | 0.030 |
Why?
| New York | 1 | 2017 | 123 | 0.030 |
Why?
| Sex Factors | 1 | 2013 | 1949 | 0.030 |
Why?
| Sepsis | 1 | 2013 | 556 | 0.030 |
Why?
| Inpatients | 1 | 2011 | 460 | 0.030 |
Why?
| Patient Education as Topic | 1 | 2021 | 734 | 0.030 |
Why?
| Body Weight | 1 | 2020 | 931 | 0.030 |
Why?
| Kaplan-Meier Estimate | 1 | 2008 | 857 | 0.030 |
Why?
| Risk | 1 | 2008 | 852 | 0.030 |
Why?
| Age Factors | 1 | 2013 | 3117 | 0.030 |
Why?
| Program Evaluation | 1 | 2019 | 874 | 0.030 |
Why?
| Communication | 1 | 2021 | 838 | 0.030 |
Why?
| Consumer Behavior | 1 | 2015 | 68 | 0.030 |
Why?
| Regression Analysis | 1 | 2017 | 983 | 0.030 |
Why?
| Time Factors | 1 | 2014 | 6503 | 0.030 |
Why?
| Surveys and Questionnaires | 1 | 2015 | 5346 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2010 | 2736 | 0.030 |
Why?
| Anti-Bacterial Agents | 1 | 2022 | 1667 | 0.020 |
Why?
| Infant, Newborn | 1 | 2019 | 5687 | 0.020 |
Why?
| Prospective Studies | 1 | 2019 | 7043 | 0.020 |
Why?
|
|
Perraillon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|